Previous 10 | Next 10 |
BEDFORD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its first quarter ended March 31, 2022. First Quarter 2022 Financial Summary ...
BEDFORD, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2022 financial results after the close of the market on Th...
BEDFORD, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate in the 21st Annual Needham Virtual Healthcare Conference on Thursday, April...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with this event. For further details see: Anika Therapeutics (ANIK) Presents at the Canaccord Genuity Musculoskeletal Conference - Slideshow
BEDFORD, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company, today announced it will showcase its comprehensive joint preservation and restoration product portfolio at the 2022 American Academy of Orthopedic Surgeons (A...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Anika Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation
Anika Therapeutics' share price is being punished by the market owing to some possibly over-ambitious growth projections made in June last year. Management believed it could nearly double revenues, to $230m, by 2024, but after a so-so 2021, these plans have been abandoned. Anika i...
BEDFORD, Mass., March 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will participate at the Canaccord Genuity Musculoskeletal Conference in Chicago, IL on Tuesd...
Gainers: Sunshine Biopharma (NASDAQ:SBFM) +183%. Bumble (NASDAQ:BMBL) +42%. Bone Biologics (OTCPK:BBLG) +36%. Cano Health (NYSE:CANO) +35%. CPS Technologies (NASDAQ:CPSH) +29%. AST SpaceMobile (NASDAQ:ASTS) +31%. Hudson Technologies (NASDAQ:HDSN) +30%. FIGS (NYSE:FIGS) +30%. Fluent (NASDAQ:FL...
Anika Therapeutics (ANIK -17.1%) stock plummeted following its Q4 results and downgrades by Stephens and Barrington Research. Stephens analyst Chris Cooley downgraded Anika to Equal Weight from Overweight with a price target of $35, down from $50, after the company reported mixed Q4 resu...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...